| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |